l 158809 has been researched along with Kidney Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, EP; Fish, BL; Moulder, JE | 2 |
| Cohen, EP; Fish, BL; Li, XA; Moulder, JE; Sharma, M | 1 |
| Cohen, EP; Datta, PK; Fish, BL; Lianos, EA; Moulder, JE | 2 |
| Beshara, G; Ghali, R; Sabra, R; Serhal, H; Sharaf, LH; Zeinoun, N | 1 |
| Cohen, EP; Fish, BL; Molteni, A; Moulder, JE; Taylor, JM; Veno, PA; Ward, WF; Wolfe, LF | 1 |
| Cohen, EP; Fish, BL; Moulder, JE; Regner, KR | 1 |
8 other study(ies) available for l 158809 and Kidney Diseases
| Article | Year |
|---|---|
Impact of angiotensin II type 2 receptor blockade on experimental radiation nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Drug Interactions; Imidazoles; Kidney Diseases; Kidney Function Tests; Male; Pyridines; Radiation Injuries, Experimental; Radiation Protection; Radiation Tolerance; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Treatment Outcome | 2004 |
Role of the angiotensin II type-2 receptor in radiation nephropathy.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cell Line; Humans; Imidazoles; Kidney Diseases; Male; Mice; Pyridines; Radiation Injuries, Experimental; Rats; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors | 2007 |
Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Imidazoles; Kidney; Kidney Diseases; Kidney Function Tests; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Survival Rate; Tetrazoles; Time Factors; Treatment Outcome | 1998 |
TGF-beta 1 production in radiation nephropathy: role of angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Female; Imidazoles; Kidney Diseases; Kidney Glomerulus; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Tetrazoles; Transforming Growth Factor beta | 1999 |
Induction of heme oxygenase 1 in radiation nephropathy: role of angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Induction; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Imidazoles; Kidney; Kidney Diseases; Rats; Tetrazoles; Transforming Growth Factor beta | 2001 |
Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity.
Topics: Amphotericin B; Angiotensin II; Animals; Antifungal Agents; Arginine; Candida albicans; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Endothelins; Glomerular Filtration Rate; Imidazoles; In Vitro Techniques; Injections, Intravenous; Kidney Diseases; Liposomes; Male; Nitric Oxide; Nitroso Compounds; Oligopeptides; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 2001 |
Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Bone Marrow Transplantation; Captopril; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Fibrosis; Imidazoles; Kidney Diseases; Male; Radiotherapy; Rats; Tetrazoles; Time Factors | 2001 |
Angiotensin II blockade reduces radiation-induced proliferation in experimental radiation nephropathy.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Cell Division; Disease Models, Animal; Imidazoles; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Proliferating Cell Nuclear Antigen; Rats; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors | 2002 |